Association of B cells in tumor microenvironment (TME) with clinical benefit to programmed cell death protein-1 (PD-1) blockade therapy in esophageal squamous cell carcinoma (ESCC).

被引:2
|
作者
Guo, Jhe-Cyuan [1 ]
Hsu, Chia-Lang [2 ]
Huang, Yen-Lin [3 ]
Lin, Chia-Chi [3 ]
Huang, Ta-Chen [3 ]
Chang, Chun-Jung [4 ]
Kuo, Hung-Yang [5 ]
Hsu, Chih-Hung [1 ]
机构
[1] Natl Taiwan Univ, Ctr Canc, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Taipei, Taiwan
[4] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
[5] Natl Taiwan Univ Hosp, Taipei, Taiwan
关键词
D O I
10.1200/JCO.2021.39.3_suppl.237
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
237
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Impact of taxanes after PD-1 blockade exposure in advanced esophageal squamous cell carcinoma
    Shiraishi, Kazuhiro
    Takeyasu, Yuki
    Yamamoto, Shun
    Oshima, Kotoe
    Imazeki, Hiroshi
    Hirano, Hidekazu
    Okita, Natsuko
    Shoji, Hirokazu
    Honma, Yoshitaka
    Iwasa, Satoru
    Takasima, Atsuo
    Kato, Ken
    ESOPHAGUS, 2024, 21 (04) : 539 - 545
  • [22] Neoadjuvant PD-1 blockade in combination with chemotherapy for patients with resectable esophageal squamous cell carcinoma
    Cheng Chao
    Yang Weixiong
    Chen Wenfang
    Yeung, Sau-Ching Jim
    Xing Xiangbin
    Wang Xiaoyan
    Bao Yong
    Feng Shiting
    Peng Fang
    Liu Zhenguo
    Zeng Bo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [23] Lesion-Level Response Dynamics to Programmed Cell Death Protein (PD-1) Blockade
    Osorio, Juan C.
    Arbour, Kathryn C.
    Le, Dung T.
    Durham, Jennifer N.
    Plodkowski, Andrew J.
    Halpenny, Darragh F.
    Ginsberg, Michelle S.
    Sawan, Peter
    Crompton, Joseph G.
    Yu, Helena A.
    Namakydoust, Azadeh
    Nabet, Barzin Y.
    Chaft, Jamie E.
    Riely, Gregory J.
    Rizvi, Hira
    Diaz, Luis A., Jr.
    Hellmann, Matthew D.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (36) : 3546 - +
  • [24] PD-1 and PD-L1 in neoplastic cells and the tumor microenvironment of Merkel cell carcinoma
    Mitteldorf, Christina
    Berisha, Arbeneshe
    Tronnier, Michael
    Pfaltz, Monique C.
    Kempf, Werner
    JOURNAL OF CUTANEOUS PATHOLOGY, 2017, 44 (09) : 740 - 746
  • [25] Concordance among three programmed death-ligand 1 (PD-L1) scoring methods and their association with clinical outcomes of tislelizumab (TIS) monotherapy in esophageal squamous cell carcinoma (ESCC).
    Shu, Yongqian
    Wang, Jufeng
    Chen, Zhendong
    Kim, Sung-Bae
    Lin, Chen-Yuan
    Kato, Ken
    Van Cutsem, Eric
    Du, Wenting
    Shi, Jingwen
    Xia, Tianyu
    Huang, Ruiqi
    Li, Qiao
    Zhang, Yun
    Shen, Zhirong
    Shen, Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 390 - 390
  • [26] PD-1 expression and clinical PD-1 blockade in B-cell lymphomas
    Xu-Monette, Zijun Y.
    Zhou, Jianfeng
    Young, Ken H.
    BLOOD, 2018, 131 (01) : 68 - 83
  • [27] Tumor immune microenvironment determinants of response to lenvatinib and a PD-1 blockade in clear cell renal cell carcinoma
    Vuong, Lynda
    Kuo, Fengshen
    Jiang, Hui
    Mascareno, Eduardo A.
    Rappold, Phillip
    Sabio, Erich
    Weiss, Kate
    Cornish, Andrew
    Reese, Stephen
    Adlesic, Mojca
    Solit, David
    Frew, Ian
    Akin, Oguz
    Chen, Yingbei
    Li, Ming O.
    Chan, Timothy A.
    Hakimi, Ari A.
    CANCER RESEARCH, 2023, 83 (16)
  • [28] Advanced Squamous Cell Carcinoma - Rapid Response to PD-1 Blockade
    Gellrich, F. F.
    Meier, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 16 - 16
  • [29] Association of programmed death-1 polymorphisms with the risk and prognosis of esophageal squamous cell carcinoma
    Zhou, Rong-Miao
    Li, Yan
    Wang, Na
    Huang, Xi
    Cao, Shi-Ru
    Shan, Bao-En
    CANCER GENETICS, 2016, 209 (09) : 365 - 375
  • [30] Tumor hypoxia is associated with resistance to PD-1 blockade in squamous cell carcinoma of the head and neck
    Zandberg, Dan P.
    Menk, Ashley V.
    Velez, Maria
    Normolle, Daniel
    DePeaux, Kristin
    Liu, Angen
    Ferris, Robert L.
    Delgoffe, Greg M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (05)